Search filters

Filters
Clear All

Phase

  • 1
  • 1
  • 1
  • 4
  • 3
  • 2
  • 148
  • 15
  • 24
  • 160
  • 187
  • 64

Found 199 Neoplasms trials

A listing of Neoplasms medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

18 - 100
All genders
This is a Phase 1, open label, multi-center study of intravenously administered DSP-0509 in adult subjects with advance solid tumors that are refractory to standard treatment.
18 - 100
All genders
The purpose of this study is to see if two investigational drugs, called MEDI4736 and tremelimumab (either drug alone or in combination) are safe in treating adult subjects with liver cancer (hepatocellular carcinoma) that cannot be removed by surgery (unresectable).
18 - 100
All genders
The purpose of this study is to compare radiation treatment plans that are designed for patients with liver cancer.
18 - 100
All genders
The purpose of this study is to test any good and bad effects of the study drug called pembrolizumab when it is given in combination with Y90 (TheraSphere?).
1 - 21
All genders
This screening and multi-sub-study phase II trial studies how well treatment that is directed by genetic testing works in pediatric patients with solid tumors, non-Hodgkin lymphomas, or histiocytic disorders that have progressed following at least one line of standard systemic therapy and/or for which no standard treatment exists that has …
18 - 100
All genders
The primary question of interest is quantifying the relationship between Y-90 liver therapy and liver damage.
18 - 100
All genders
This is an open label, single arm phase 1 dose escalation study and phase 2 study of BBI608 in combination with paclitaxel in patients with advanced malignancies.
18 - 100
Accepts healthy volunteer
All genders
The purpose of this study is to evaluate anti-tumor capabilities of urine with and without physical exercise, and examine linkage of anti-tumor capabilities to the concentrations of cholesterol and dopamine in the urine.
11 - 45
All genders
The purpose of this study is to determine if accelerated BEP will be more effective but not significantly more toxic than standard BEP.
18 - 100
Male
The purpose of this study is to establish the recommended phase 2 dose (RP2D) of ASP1650 (Safety Lead-in Phase), as well as, evaluate the efficacy of ASP1650 as measured by confirmed objective response rate (ORR) (phase 2) in participants with incurable platinum refractory germ cell tumors.
61 - 70 of 199